Inventor
GRIFFIN ROGER JOHN
GB24 patents
⚠️ This page may combine multiple inventors who share the name “GRIFFIN ROGER JOHN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
KUDOS PHARM LTD
6 patentsUS7402607B2Jul 22, 2008
DNA-PK inhibitors
KUDOS PHARM LTD16 citations91
US7049313B2May 23, 2006
ATM inhibitors
KUDOS PHARM LTD19 citations80
US7429660B2Sep 30, 2008
ATM inhibitors
KUDOS PHARM LTD4 citations62
US7696203B2Apr 13, 2010
DNA-PK inhibitors
KUDOS PHARM LTD4 citations59
US7642254B2Jan 5, 2010
ATM inhibitors
KUDOS PHARM LTD0 citations51
US7732483B2Jun 8, 2010
DNA-PK inhibitors
KUDOS PHARM LTD0 citations50
UNIV NEWCASTLE VENTURES LTD
5 patentsUS5756510AMay 26, 1998
Benzamide analogs useful as PARP (ADP-ribosyltransferase, ADPRT) DNA repair enzyme inhibitors
UNIV NEWCASTLE VENTURES LTD98 citations96
US6100283AAug 8, 2000
Benzimidazole compounds
UNIV NEWCASTLE VENTURES LTD49 citations93
US6015827AJan 18, 2000
Benzoxazole-4-carboxamides and their use in inhibiting poly (adp-ribose) polymerase activity and improving cytotoxic effectiveness of cytotoxic drugs or radiotherapy
UNIV NEWCASTLE VENTURES LTD28 citations91
US6156739ADec 5, 2000
Quinazolinone compounds
UNIV NEWCASTLE VENTURES LTD46 citations89
US6316455B1Nov 13, 2001
Method of improving the effectiveness of a cytotoxic drug or radiotherapy using a quinazolinone compound
UNIV NEWCASTLE VENTURES LTD14 citations81
ASTEX THERAPEUTICS LTD
5 patentsUS10544132B2Jan 28, 2020
Isoindolinone inhibitors of the MDM2-p53 interaction having anticancer activity
ASTEX THERAPEUTICS LTD10 citations82
US10526311B2Jan 7, 2020
Isoindolinone inhibitors of the MDM2-P53 interaction having anticancer activity
ASTEX THERAPEUTICS LTD6 citations82
US11261171B1Mar 1, 2022
Isoindolinone inhibitors of the MDM2-P53 interaction having anticancer activity
ASTEX THERAPEUTICS LTD2 citations71
US10981898B2Apr 20, 2021
Isoindolinone inhibitors of the MDM2-p53 interaction having anticancer activity
ASTEX THERAPEUTICS LTD4 citations71
US12071429B2Aug 27, 2024
Isoindolinone inhibitors of the MDM2-P53 interaction having anticancer activity
ASTEX THERAPEUTICS LTD0 citations60
CANCER REC TECH LTD
4 patentsUS9358222B2Jun 7, 2016
Therapeutic agents
CANCER REC TECH LTD9 citations81
US7674823B2Mar 9, 2010
DNA-PK inhibitors
CANCER REC TECH LTD3 citations60
US7226918B2Jun 5, 2007
DNA-PK inhibitors
CANCER REC TECH LTD4 citations60
US7105518B2Sep 12, 2006
Thiopyrane-4-ones as DNA protein kinase inhibitors
CANCER REC TECH LTD5 citations60